COPD: GSK launches once daily, single inhaler-triple therapy for COPD patients
GlaxoSmithKline Prescription drugs on Tuesday stated it has launched Trelegy Ellipta for Persistent Obstructive Pulmonary Illness (COPD) sufferers. Trelegy Ellipta ...
GlaxoSmithKline Prescription drugs on Tuesday stated it has launched Trelegy Ellipta for Persistent Obstructive Pulmonary Illness (COPD) sufferers. Trelegy Ellipta ...
Copyright © 2022 Asia Today.